SG11201407576YA - Difluoro-hexahydro-cyclopentaoxazinyls and difluoro-hexahydro-benzooxazinyls as bace1 inhibitors - Google Patents
Difluoro-hexahydro-cyclopentaoxazinyls and difluoro-hexahydro-benzooxazinyls as bace1 inhibitorsInfo
- Publication number
- SG11201407576YA SG11201407576YA SG11201407576YA SG11201407576YA SG11201407576YA SG 11201407576Y A SG11201407576Y A SG 11201407576YA SG 11201407576Y A SG11201407576Y A SG 11201407576YA SG 11201407576Y A SG11201407576Y A SG 11201407576YA SG 11201407576Y A SG11201407576Y A SG 11201407576YA
- Authority
- SG
- Singapore
- Prior art keywords
- hexahydro
- difluoro
- cyclopentaoxazinyls
- benzooxazinyls
- bace1 inhibitors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/536—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with carbocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
- C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12173690 | 2012-06-26 | ||
| PCT/EP2013/063086 WO2014001228A1 (en) | 2012-06-26 | 2013-06-24 | Difluoro-hexahydro-cyclopentaoxazinyls and difluoro-hexahydro-benzooxazinyls as bace1 inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201407576YA true SG11201407576YA (en) | 2015-03-30 |
Family
ID=48672630
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201407576YA SG11201407576YA (en) | 2012-06-26 | 2013-06-24 | Difluoro-hexahydro-cyclopentaoxazinyls and difluoro-hexahydro-benzooxazinyls as bace1 inhibitors |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US9181232B2 (pt) |
| EP (1) | EP2864324B1 (pt) |
| JP (1) | JP6251257B2 (pt) |
| KR (1) | KR20150023450A (pt) |
| CN (1) | CN104470915B (pt) |
| AU (1) | AU2013283524B2 (pt) |
| BR (1) | BR112014029742A2 (pt) |
| CA (1) | CA2872181A1 (pt) |
| CL (1) | CL2014003325A1 (pt) |
| CO (1) | CO7151509A2 (pt) |
| CR (1) | CR20140528A (pt) |
| EA (1) | EA025273B1 (pt) |
| HK (1) | HK1206344A1 (pt) |
| IL (1) | IL236138A (pt) |
| MA (1) | MA37763B1 (pt) |
| MX (1) | MX2014014937A (pt) |
| NZ (1) | NZ702253A (pt) |
| PE (1) | PE20142450A1 (pt) |
| PH (1) | PH12014502623B1 (pt) |
| SG (1) | SG11201407576YA (pt) |
| UA (1) | UA113309C2 (pt) |
| WO (1) | WO2014001228A1 (pt) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8637504B2 (en) | 2008-06-13 | 2014-01-28 | Shionogi & Co., Ltd. | Sulfur-containing heterocyclic derivative having beta secretase inhibitory activity |
| RU2012129168A (ru) | 2009-12-11 | 2014-01-20 | Сионоги Энд Ко. Лтд. | Производные оксазина |
| WO2014065434A1 (en) | 2012-10-24 | 2014-05-01 | Shionogi & Co., Ltd. | Dihydrooxazine or oxazepine derivatives having bace1 inhibitory activity |
| EP2961749B1 (en) | 2013-03-01 | 2019-10-09 | Amgen Inc. | Perfluorinated 5,6-dihydro-4h-1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use |
| CA2903215C (en) | 2013-03-08 | 2021-07-20 | Amgen Inc. | Perfluorinated cyclopropyl fused 1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use |
| TW201623295A (zh) | 2014-04-11 | 2016-07-01 | 塩野義製藥股份有限公司 | 具有ｂａｃｅ１抑制活性之二氫噻及二氫衍生物 |
| US9550762B2 (en) | 2014-08-08 | 2017-01-24 | Amgen, Inc. | Cyclopropyl fused thiazin-2-amine compounds as beta-secretase inhibitors and methods of use |
| RU2712272C2 (ru) | 2015-03-20 | 2020-01-28 | Ф. Хоффманн-Ля Рош Аг | Ингибиторы бета-секретазы |
| AU2019258575A1 (en) | 2018-04-27 | 2020-10-29 | Shionogi & Co., Ltd. | Tetrahydropyranooxazine derivatives having selective BACE1 inhibitory activity |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2360155A4 (en) | 2008-10-22 | 2012-06-20 | Shionogi & Co | 2-AMINOPYRIDIN-4-ON AND 2-AMINOPYRIDINE DERIVATIVE WITH BACE1-HEMDERING EFFECT |
| GB0912778D0 (en) | 2009-07-22 | 2009-08-26 | Eisai London Res Lab Ltd | Fused aminodihydro-oxazine derivatives |
| RU2012129168A (ru) | 2009-12-11 | 2014-01-20 | Сионоги Энд Ко. Лтд. | Производные оксазина |
| UA103272C2 (uk) * | 2009-12-11 | 2013-09-25 | Ф. Хоффманн-Ля Рош Аг | 2-аміно-5,5-дифтор-5,6-дигідро-4h-оксазини як інгібітори bace1 і/або bace2 |
-
2013
- 2013-06-24 CN CN201380033783.7A patent/CN104470915B/zh not_active Expired - Fee Related
- 2013-06-24 JP JP2015519008A patent/JP6251257B2/ja not_active Expired - Fee Related
- 2013-06-24 US US14/406,289 patent/US9181232B2/en not_active Expired - Fee Related
- 2013-06-24 BR BR112014029742A patent/BR112014029742A2/pt not_active IP Right Cessation
- 2013-06-24 EA EA201590066A patent/EA025273B1/ru not_active IP Right Cessation
- 2013-06-24 PE PE2014002406A patent/PE20142450A1/es not_active Application Discontinuation
- 2013-06-24 NZ NZ702253A patent/NZ702253A/en not_active IP Right Cessation
- 2013-06-24 MA MA37763A patent/MA37763B1/fr unknown
- 2013-06-24 CA CA2872181A patent/CA2872181A1/en not_active Abandoned
- 2013-06-24 KR KR20147036016A patent/KR20150023450A/ko not_active Application Discontinuation
- 2013-06-24 SG SG11201407576YA patent/SG11201407576YA/en unknown
- 2013-06-24 EP EP13730887.0A patent/EP2864324B1/en not_active Not-in-force
- 2013-06-24 WO PCT/EP2013/063086 patent/WO2014001228A1/en active Application Filing
- 2013-06-24 MX MX2014014937A patent/MX2014014937A/es unknown
- 2013-06-24 UA UAA201500578A patent/UA113309C2/uk unknown
- 2013-06-24 AU AU2013283524A patent/AU2013283524B2/en not_active Expired - Fee Related
-
2014
- 2014-11-18 CR CR20140528A patent/CR20140528A/es unknown
- 2014-11-24 PH PH12014502623A patent/PH12014502623B1/en unknown
- 2014-12-05 CL CL2014003325A patent/CL2014003325A1/es unknown
- 2014-12-08 IL IL236138A patent/IL236138A/en not_active IP Right Cessation
- 2014-12-10 CO CO14271199A patent/CO7151509A2/es unknown
-
2015
- 2015-07-21 HK HK15106931.2A patent/HK1206344A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| MX2014014937A (es) | 2015-03-09 |
| KR20150023450A (ko) | 2015-03-05 |
| PE20142450A1 (es) | 2015-01-28 |
| EP2864324A1 (en) | 2015-04-29 |
| MA37763B1 (fr) | 2017-05-31 |
| US20150133440A1 (en) | 2015-05-14 |
| US9181232B2 (en) | 2015-11-10 |
| JP6251257B2 (ja) | 2017-12-20 |
| CN104470915A (zh) | 2015-03-25 |
| AU2013283524A1 (en) | 2014-11-13 |
| HK1206344A1 (en) | 2016-01-08 |
| PH12014502623A1 (en) | 2015-01-21 |
| EA025273B1 (ru) | 2016-12-30 |
| IL236138A (en) | 2016-10-31 |
| JP2015521640A (ja) | 2015-07-30 |
| MA37763A1 (fr) | 2016-08-31 |
| NZ702253A (en) | 2016-06-24 |
| IL236138A0 (en) | 2015-02-01 |
| CO7151509A2 (es) | 2014-12-29 |
| CA2872181A1 (en) | 2014-01-03 |
| BR112014029742A2 (pt) | 2017-06-27 |
| CL2014003325A1 (es) | 2015-04-24 |
| EP2864324B1 (en) | 2018-03-28 |
| AU2013283524B2 (en) | 2017-03-30 |
| UA113309C2 (xx) | 2017-01-10 |
| CR20140528A (es) | 2015-01-12 |
| WO2014001228A1 (en) | 2014-01-03 |
| EA201590066A1 (ru) | 2015-04-30 |
| CN104470915B (zh) | 2019-07-26 |
| PH12014502623B1 (en) | 2015-01-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20182037T1 (hr) | Inhibitori prmt5 i njihova uporaba | |
| HK1202545A1 (en) | New diazaspirocycloalkane and azaspirocycloalkane | |
| PL2920149T3 (pl) | Związki 3-aminocykloalkilowe jako inhibitory ror-gamma-t oraz ich zastosowania | |
| EP2890678A4 (en) | GLYCOSIDASE INHIBITORS AND USES THEREOF | |
| IL265496A (en) | bace1 inhibitors | |
| HK1198827A1 (en) | Dyrk1 inhibitors and uses thereof dyrk1 | |
| EP2890679A4 (en) | GLYCOSIDASE INHIBITORS AND USES THEREOF | |
| EP2935283A4 (en) | GLYCOSIDASE INHIBITORS AND USES THEREOF | |
| EP2914604A4 (en) | GLYCOSIDASE INHIBITORS AND ASSOCIATED APPLICATIONS | |
| EP2890676A4 (en) | GLYCOSIDASE INHIBITORS AND USES THEREOF | |
| EP2890675A4 (en) | GLYCOSIDASE INHIBITORS AND USES THEREOF | |
| IL236138A (en) | Dipluoro-hexahydro-cyclophenoxazinyls and diplooro-hexahydro-benzooxazinyls as bace inhibitors1 | |
| HK1209422A1 (en) | Fbxo3 inhibitors fbxo3 | |
| HK1206350A1 (en) | 2h-imidazol-4-amine compounds and their use as bace inhibitors 2h--4- bace | |
| GB201315350D0 (en) | Methods and compositions | |
| GB201315347D0 (en) | Methods and compositions | |
| GB201223308D0 (en) | Enzyme inhibitors | |
| GB201222541D0 (en) | Kiddibidet and pottibidet | |
| IL218974A0 (en) | Conaction bitwen coutch and playels | |
| GB201202021D0 (en) | Co-sleeper and breastfeeder |